VEGFA, the main isoform of VEGF, can be blocked by Bevacizumab, a monoclonal antibody, or by a "fusion protein", VEGF Trap, built using Fc fragments of IgG fused to VEGFR1 domain 2 and VEGFR2 domain 3. VEGF Trap is in clinical trials for cancer and approved for AMD.
Back to home page
(aflibercept, TM Zaltrap & Eylea)
see details of how VEGF TRAP makes use of FLT1 & KDR
You can block VEGF with a monoclonal antibody, Bevacizumab, or Ranibizumab
You can trap VEGF with a decoy construct, a "fusion protein", built with:
- elements of VEGF receptors:
  - Domain 2 of VEGFr1 and
  - Domain 3 of VEGFr2
added to
- fragments of immunoglobulin (Fc of IgG1)